NextPoint Therapeutics is a clinical-stage immune-oncology biotechnology company that develops tumor-targeting antibodies targeting the B7-H7/HHLA2 pathway.
Arkin Entry Stage
Clinical
Status
Active
Location
Cambridge, MA
Let’s get in touch!
